186 related articles for article (PubMed ID: 36923927)
1. N
Zheng H; Cheng ZJ; Liang B; Wang ZG; Tao YP; Huang SY; Ni JS; Li HF; Yang L; Yuan SX; Wu J; Kawaguchi T; Samant H; Zhou WP; Xiang DM; Yang Y
Int J Biol Sci; 2023; 19(4):1009-1023. PubMed ID: 36923927
[TBL] [Abstract][Full Text] [Related]
2. RNA m
Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G
EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828
[TBL] [Abstract][Full Text] [Related]
3. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
[TBL] [Abstract][Full Text] [Related]
4. METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.
Hu J; Yang L; Peng X; Mao M; Liu X; Song J; Li H; Chen F
Hum Cell; 2022 Nov; 35(6):1838-1855. PubMed ID: 36087219
[TBL] [Abstract][Full Text] [Related]
5. Multiple m
Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
[TBL] [Abstract][Full Text] [Related]
6. Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.
Su T; Huang M; Liao J; Lin S; Yu P; Yang J; Cai Y; Zhu S; Xu L; Peng Z; Peng S; Chen S; Kuang M
Hepatology; 2021 Sep; 74(3):1339-1356. PubMed ID: 33638162
[TBL] [Abstract][Full Text] [Related]
7. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma.
Xu H; Wang H; Zhao W; Fu S; Li Y; Ni W; Xin Y; Li W; Yang C; Bai Y; Zhan M; Lu L
Theranostics; 2020; 10(13):5671-5686. PubMed ID: 32483411
[No Abstract] [Full Text] [Related]
8. Anillin is required for tumor growth and regulated by miR-15a/miR-16-1 in HBV-related hepatocellular carcinoma.
Lian YF; Huang YL; Wang JL; Deng MH; Xia TL; Zeng MS; Chen MS; Wang HB; Huang YH
Aging (Albany NY); 2018 Aug; 10(8):1884-1901. PubMed ID: 30103211
[TBL] [Abstract][Full Text] [Related]
9. An Alternatively Spliced Variant of METTL3 Mediates Tumor Suppression in Hepatocellular Carcinoma.
Xu RY; Ding Z; Zhao Q; Ke TY; Chen S; Wang XY; Wang YY; Sheng MF; Wang W; Long N; Shen YX; Xu YZ; Shao W
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456475
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma.
Zhang LH; Wang D; Li Z; Wang G; Chen DB; Cheng Q; Hu SH; Zhu JY
Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):337-344. PubMed ID: 32933876
[TBL] [Abstract][Full Text] [Related]
11. Reduced N6-Methyladenosine Mediated by METTL3 Acetylation Promotes MTF1 Expression and Hepatocellular Carcinoma Cell Growth.
Yang Y; Qian Cai Q; Sheng Fu L; Wei Dong Y; Fan F; Zhong Wu X
Chem Biodivers; 2022 Nov; 19(11):e202200333. PubMed ID: 36149370
[TBL] [Abstract][Full Text] [Related]
12. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
[TBL] [Abstract][Full Text] [Related]
13. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
Zhang S; Nguyen LH; Zhou K; Tu HC; Sehgal A; Nassour I; Li L; Gopal P; Goodman J; Singal AG; Yopp A; Zhang Y; Siegwart DJ; Zhu H
Gastroenterology; 2018 Apr; 154(5):1421-1434. PubMed ID: 29274368
[TBL] [Abstract][Full Text] [Related]
15. p53 m
Ke W; Zhang L; Zhao X; Lu Z
Apoptosis; 2022 Jun; 27(5-6):426-440. PubMed ID: 35503144
[TBL] [Abstract][Full Text] [Related]
16. Roles of M
Chen J; Zhang Q; Liu T; Tang H
Curr Gene Ther; 2022; 22(1):40-50. PubMed ID: 34825870
[TBL] [Abstract][Full Text] [Related]
17. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
[No Abstract] [Full Text] [Related]
18. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.
Chen SL; Liu LL; Wang CH; Lu SX; Yang X; He YF; Zhang CZ; Yun JP
Mol Oncol; 2020 Feb; 14(2):373-386. PubMed ID: 31670863
[TBL] [Abstract][Full Text] [Related]
19. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
[TBL] [Abstract][Full Text] [Related]
20. Analysis of METTL3 and METTL14 in hepatocellular carcinoma.
Liu X; Qin J; Gao T; Li C; Chen X; Zeng K; Xu M; He B; Pan B; Xu X; Pan Y; Sun H; Xu T; Wang S
Aging (Albany NY); 2020 Nov; 12(21):21638-21659. PubMed ID: 33159022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
